Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Infection Control and Hospital Epidemiology|October 17, 2015
Universal vs Risk Factor Screening for Methicillin-Resistant Staphylococcus aureus in a Large Multicenter Tertiary Care Facility in CanadaV R Roth, T Longpre, M Taljaard, et al.
Atherosclerosis|February 18, 2014
Chronic kidney disease on hemodialysis is associated with decreased serum PCSK9 levelsH Abujrad, J Mayne, M Ruzicka, et al.
Osteoarthritis and Cartilage|August 9, 2015
Impact of patient decision aids on appropriate and timely access to hip or knee arthroplasty for osteoarthritis: a randomized controlled trialD Stacey, M Taljaard, G Dervin, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 11, 2015
Relationship between testosterone, estradiol and circulating PCSK9: Cross-sectional and interventional studies in humansT C Ooi, A Raymond, M Cousins, et al.
Current Oncology (Toronto, Ont.)|July 10, 2019
Testing e-mail content to encourage physicians to access an audit and feedback tool: a factorial randomized experimentG Vaisson, H O Witteman, S Chipenda-Dansokho, et al.
BMJ (Clinical Research Ed.)|September 28, 2011
Impact of CONSORT extension for cluster randomised trials on quality of reporting and study methodology: review of random sample of 300 trials, 2000-8N M Ivers, M Taljaard, S Dixon, et al.
Public Health|June 16, 2026
Changes in the proximity of alcohol outlets to schools after the introduction of convenience store alcohol sales in Ontario, Canada: A descriptive studyE L Friesen, R MacDonald-Spracklin, M Taljaard, et al.
Implementation Science : IS|October 23, 2015
Protocol for the development of a CONSORT-equity guideline to improve reporting of health equity in randomized trialsVivian Welch, J Jull, J Petkovic, et al.
BMJ Open|September 28, 2017
When is a randomised controlled trial health equity relevant? Development and validation of a conceptual frameworkJ Jull, M Whitehead, M Petticrew, et al.
Clinical Pharmacology and Therapeutics|November 8, 2012
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysisE Danese, M Montagnana, J A Johnson, et al.
Pageof 3